Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Paganelli

Showing results (31-40 of 213) with videos related to

Pageof 22
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|April 23, 2004
Sentinel node detection in pre-operative axillary stagingGiuseppe Trifirò, Giuseppe Viale, Oreste Gentilini, et al.
Clinical Nuclear Medicine|May 4, 2013
Ipilimumab-induced immunomediated adverse events: possible pitfalls in (18)F-FDG PET/CT interpretationLaura Gilardi, Marzia Colandrea, Stefano Vassallo, et al.
Lancet (London, England)|August 8, 2021
Targeted radioactive therapy for prostate cancerUgo De Giorgi, Vincenza Conteduca, Giorgia Gurioli, et al.
Clinical Endocrinology|August 14, 2013
(68) Ga- DOTA(0) -Tyr(3) octreotide (DOTATOC) positron emission tomography (PET)/CT in five cases of ectopic adrenocorticotropin-secreting tumoursLaura Gilardi, Marzia Colandrea, Silvia L Fracassi, et al.
Ecancermedicalscience|July 11, 2013
Intramedullary spinal cord metastases from breast cancer: detection with (18)F-FDG PET/CTLaura Gilardi, Stefano Vassallo, Marzia Colandrea, et al.
Seminars in Nuclear Medicine|April 20, 2002
In- and Y-DOTA-lanreotide: results and implications of the MAURITIUS trialIrene Virgolini, Keith Britton, John Buscombe, et al.
Neurological Research|July 1, 2006
Radioimmunotherapy of brain tumorGiovanni Paganelli, Mirco Bartolomei, Chiara Grana, et al.
Biochimica Et Biophysica Acta|June 21, 2005
Preparation and characterization of active site protected poly(ethylene glycol)-avidin bioconjugatesStefano Salmaso, Alessandra Semenzato, Sara Bersania, et al.
Oncotargets and Therapy|February 17, 2017
Peptide receptor radionuclide therapy in the management of gastrointestinal neuroendocrine tumors: efficacy profile, safety, and quality of lifeStefano Severi, Ilaria Grassi, Silvia Nicolini, et al.
The Lancet. Oncology|May 3, 2019
Early use of abiraterone and radium-223 in metastatic prostate cancerMaria Concetta Cursano, Daniele Santini, Michele Iuliani, et al.
Pageof 22

Showing results (31-40 of 213) with videos related to

Sort By:
Pageof 22
European Journal of Nuclear Medicine and Molecular Imaging|April 23, 2004
Sentinel node detection in pre-operative axillary stagingGiuseppe Trifirò, Giuseppe Viale, Oreste Gentilini, et al.
Clinical Nuclear Medicine|May 4, 2013
Ipilimumab-induced immunomediated adverse events: possible pitfalls in (18)F-FDG PET/CT interpretationLaura Gilardi, Marzia Colandrea, Stefano Vassallo, et al.
Lancet (London, England)|August 8, 2021
Targeted radioactive therapy for prostate cancerUgo De Giorgi, Vincenza Conteduca, Giorgia Gurioli, et al.
Clinical Endocrinology|August 14, 2013
(68) Ga- DOTA(0) -Tyr(3) octreotide (DOTATOC) positron emission tomography (PET)/CT in five cases of ectopic adrenocorticotropin-secreting tumoursLaura Gilardi, Marzia Colandrea, Silvia L Fracassi, et al.
Ecancermedicalscience|July 11, 2013
Intramedullary spinal cord metastases from breast cancer: detection with (18)F-FDG PET/CTLaura Gilardi, Stefano Vassallo, Marzia Colandrea, et al.
Seminars in Nuclear Medicine|April 20, 2002
In- and Y-DOTA-lanreotide: results and implications of the MAURITIUS trialIrene Virgolini, Keith Britton, John Buscombe, et al.
Neurological Research|July 1, 2006
Radioimmunotherapy of brain tumorGiovanni Paganelli, Mirco Bartolomei, Chiara Grana, et al.
Biochimica Et Biophysica Acta|June 21, 2005
Preparation and characterization of active site protected poly(ethylene glycol)-avidin bioconjugatesStefano Salmaso, Alessandra Semenzato, Sara Bersania, et al.
Oncotargets and Therapy|February 17, 2017
Peptide receptor radionuclide therapy in the management of gastrointestinal neuroendocrine tumors: efficacy profile, safety, and quality of lifeStefano Severi, Ilaria Grassi, Silvia Nicolini, et al.
The Lancet. Oncology|May 3, 2019
Early use of abiraterone and radium-223 in metastatic prostate cancerMaria Concetta Cursano, Daniele Santini, Michele Iuliani, et al.
Pageof 22